Key facts
- It has raised $1.2M; the latest was Later Stage VC ($120K) in Aug 2024.
- Notable investors include Indian Angel Network, BIRAC, Venture Center, IKP EDEN, Indian Department of Science and Technology — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Serigen
- ·The full record, as it builds
Funding rounds
No funding rounds for Serigen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Serigen
Developer of biomedical products designed to provide bioabsorbable implants for soft and hard tissue repair. The company's products are for human bone defects like bony voids, long bone defects, and traumatic and surgical osseous defects, enabling consumers to utilize osteoconductive bone graft substitutes based on silk fibroin material, a non-adherent wound dressing.
- Sector
- Healthcare
- HQ
- Pune, India
- Founded
- 2015
- Employees
- 35
- Website
- serigenmed.com/
- Ownership
- Privately Held (backing)
Serigen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Serigen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Serigen in its N-PORT filings yet. We sweep new filings monthly.